On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

Vice Chairman of the Standing Committee of the Fourteenth National People's Congress, He Wei, Chairman of the Central Committee of the Chinese Peasants and Workers Democratic Party, Deng Rongling, Vice Chairman of the Central Committee of the Chinese Peasants and Workers Democratic Party, Yu Xuejun, Deputy Director of the National Health and Health Commission, Li Yanyi, Vice Governor of the People's Government of Zhejiang Province, National Disease Control and Prevention Shen Hongbing, deputy director of the bureau and director of the Center for Disease Control and Prevention, and other leaders attended the meeting and delivered speeches or keynote speeches.

The meeting successfully released the "Hangzhou Declaration on Health Promotion", and specially invited Mr. Bai Yansong, a news commentator of CCTV and propagandist of China's Health Knowledge Dissemination Incentive Program, and Ms. Xu Ting, the chief anchor of Zhejiang Satellite TV and the image ambassador of Healthy Zhejiang, to read the declaration.

Huibang Biotech participated in this event as a representative of the business community, studied and actively practiced the "Hangzhou Declaration on Health Promotion", and under the consensus of "One World, One Health", gathered social forces, improved professional forces, strengthened scientific and technological forces, and mobilized volunteer forces , Motivate individuals to work together to promote public health and build a better homeland.

At the sub-forum on diabetes education and management in the afternoon, Huibang Biology held a special satellite meeting on early screening of diabetic nephropathy.

Zhang Qiu, member of the Standing Committee of the Diabetes Branch of the Chinese Medical Association (9th session), leader of the Diabetes Education and Management Group (9th session), and director of the Department of Endocrinology at the First Affiliated Hospital of Anhui Medical University, served as the host. Director Zhang enthusiastically addressed the participants Introduce Huibang Biotechnology, a rising high-tech national enterprise in Hefei, has innovatively developed early screening reagents for diabetic nephropathy, which can screen diabetic nephropathy earlier than urine microalbumin.

Liu Jianying, chairman of the Jiangxi Provincial Endocrinology Branch, member of the Standing Committee of the Endocrinology and Metabolism Physician Branch of the Chinese Medical Doctor Association, member of the Standing Committee of the Diabetes Education and Management Branch of the China Health Promotion and Education Association, and director of the Endocrinology Department of the First Affiliated Hospital of Nanchang Medical University, gave a lecture on "kidney" foresight , a "bead" in the lead - DKD's new detection reagent urinary haptoglobin.

Director Liu Jianying preached the management strategy of diabetic nephropathy from four dimensions:

1. The prevention and treatment of DKD should emphasize early screening, early diagnosis, early treatment, and integrated management. Intervention of risk factors: hyperglycemia, hypertension, abnormal blood lipid metabolism, overweight and obesity, thereby delaying the progress of DKD;

2. Strengthen patient publicity and education, and promote lifestyle management;

3. Improve physicians’ awareness and diagnosis of the importance of early screening

4. Medical institutions promote multidisciplinary collaborative diagnosis and treatment and provide clinical guidance to grassroots institutions

Then lead to the screening indicators of diabetic nephropathy: albumin, eGFR, cystatin C, β2 microglobulin and specific indicators urinary haptoglobin. Brosius et al. found that only urinary haptoglobin (urinary HP) could independently predict the risk of DKD progression, and its predictive value was better than that of proteinuria.

Professor Xue Yaoming, Director of the Department of Endocrinology, The First Affiliated Hospital of Southern Medical University, etc.: Urinary haptoglobin is an independent predictor of early renal dysfunction, and it can be used as an effective biomarker for early renal disease. Regular screening is helpful for early detection and diagnosis, so as to delay the DKD progress. Academician Chen Xiangmei from PLA General Hospital pointed out in the review that cost-benefit analysis showed that DKD screening in newly diagnosed T2DM patients can save medical expenses. Urinary haptoglobin index makes up for the deficiency of urinary microalbumin, which is more specific, sensitive and early, and is one of the major innovations of Huibang system.

Huibang Bio is honored to participate in the first China Health Promotion Conference as a representative of the business community. In the future work, it will actively implement the Hangzhou Declaration and contribute to the construction of a healthy China.